Bugworks Research Inc. and Cytecare Cancer Hospitals announce ... - 19 September 2022 13:30

BENGALURU, India, September 19, 2022 /PRNewswire-AsiaNet/ -- - Bugworks - a US, India and Australia based start-up with globally recognized expertise in drug discovery, has set up a dedicated Immuno-oncology ex vivo research lab at the Bengaluru-based hospital, Cytecare. - The lab bridges the trans...

  MagicTouch SCB receives IDE approval for In-Stent Restenosis i... - 18 September 2022 07:45

TAMPA, Fla., Sept. 17, 2022 /PRNewswire-AsiaNet/ -- The US FDA has granted an Investigational Device Exemption (IDE) approval for MagicTouch [ https://www.conceptmedical.com/product/magic-touch/ ] Sirolimus Coated Balloon (SCB) indicated for In-Stent Restenosis (ISR). US FDA's IDE approval allow...

  Nippon Express Obtains GDP Certification of Compliance with WH... - 14 September 2022 16:00

TOKYO, Sept. 14, 2022 /Kyodo JBN-AsiaNet/-- - Dedicated Pharmaceutical Logistics Facility Offers Storage and Transport in Two Temperature Ranges - Nippon Express Co., Ltd. (hereafter "Nippon Express"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired Good Distribution Pract...

  TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redef... - 14 September 2022 00:36

BIRMINGHAM, England, Sept. 13, 2022 /PRNewswire-AsiaNet/ -- Concept Medical (https://www.conceptmedical.com/) announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch (https://www.conceptmedical.com/product/magic-touch/) ...

  Turn Biotechnologies launches eTurna(TM) delivery platform des... - 13 September 2022 22:09

MOUNTAIN VIEW, Calif., Sept. 13, 2022 /PRNewswire-AsiaNet/ -- -- The proprietary platform is versatile, equally effective with different cargoes, routes of administration Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today an...

  DarwinHealth Publication Reports Step-by-Step Protocol for its... - 12 September 2022 20:00

NEW YORK, Sept. 12, 2022 /PRNewswire-AsiaNet/ -- DarwinHealth, Inc., (www.DarwinHealth.com) a New York-based biotechnology and cancer drug discovery company announces the September 9, 2022 online publication in Current Protocols (Wiley Science) of their proprietary cancer drug discovery and vali...

  EpiVax Secures Additional Funding from FDA for Immunogenicity ... - 12 September 2022 19:59

PROVIDENCE, R.I., Sept. 12, 2022 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") is pleased to announce the award of a two-year, $2 million grant from the FDA's Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) fo...

  MASSIMO CALAFIORE APPOINTED AS NEW LIMACORPORATE CEO - 12 September 2022 19:00

VILLANOVA DI SAN DANIELE DEL FRIULI, UDINE, ITALY, Sep 12, 2022 /PRNewswire-AsiaNet/-- LimaCorporate, a leading global orthopedic manufacturer focused on digital innovation and patient-tailored devices, today announces that Massimo Calafiore has been appointed by the Board of Directors as the new Chief Executive Officer of the compa...

  FDI WORLD DENTAL FEDERATION LAUNCHES TOOLKIT ON HOW TO MAKE DE... - 12 September 2022 16:00

GENEVA, Sept. 12, 2022, /PRNewswire-AsiaNet/-- Dental practices can use the tools as a guide to make their work more environmentally sustainable and by tracking progress they can achieve recognition awards for their efforts. FDI World Dental Federation (FDI) today launched a Toolkit for S...

  First patient enrolled in Erectile Dysfunction prospective ran... - 12 September 2022 08:47

GENEVA, Switzerland, Sept. 10, 2022 /PRNewswire-AsiaNet/ -- An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon. The PERFECT-SELU...